Recherche
-
Safety of antituberculosis agents used for multidrug-resistant tuberculosis among patients attending the Jamot Hospital of Yaounde, Cameroon
(International Journal of Mycobacteriology. vol. 12, n° 2, pp. 168-174, 2023-06-15)Article de revueLibre accès -
Interpretation of Pharmacovigilance Disproportionality Analyses
(Clinical Pharmacology and Therapeutics, 2023-05-30)Article de revue -
Adverse Drug Reaction-Related to Drug Shortage: A Retrospective Study on the French National Pharmacovigilance Database
(British Journal of Clinical Pharmacology. vol. 89, n° 3, pp. 1080-1088, 2023-03)Article de revueLibre accès -
Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase((R)))
(Antibiotics. vol. 12, n° 5, 2023-04-25)Article de revueLibre accès -
Invasive fungal infection incidence and risk factors in patients receiving ibrutinib in real-life settings: A nationwide population-based cohort study
(Mycoses, 2023-11-20)Article de revue -
Pharmacological Evaluation of Signals of Disproportionality Reporting Related to Adverse Reactions to Antiepileptic Cannabidiol in VigiBase
(Pharmaceuticals (Basel). vol. 16, n° 10, pp. 1420, 2023-10-05)Article de revueLibre accès -
Analgesic switching in chronic users of dextropropoxyphene in France
(Fundamental & Clinical Pharmacology, 2023-10-21)Article de revueLibre accès -
Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data
(Drug Safety. vol. 45, n° 5, pp. 535-548, 2022-05)Article de revueLibre accès -
Artificial intelligence for unstructured healthcare data: application to coding of patient reporting of adverse drug reactions
(Clinical Pharmacology and Therapeutics, 2021-04-18)Article de revueLibre accès -
Second-degree burn induced by high-concentration topical capsaicin with mobility sequelae: a case report
(Pain Practice. vol. 23, n° 2, pp. 216-219, 2023-02)Article de revueLibre accès